share_log

红日药业(300026.SZ)：2023年度净利润降18.84%至5.07亿元 拟10派0.3元

Red Sun Pharmaceutical (300026.SZ): Net profit for 2023 will drop 18.84% to 507 million yuan, and plans to distribute 10 to 0.3 yuan

Gelonghui Finance ·  Mar 28 09:30

Gelonghui March 28 | Hongri Pharmaceutical (300026.SZ) released its 2023 annual report. In 2023, the company achieved operating income of 6.109 billion yuan, a year-on-year decrease of 8.14%; net profit attributable to shareholders of listed companies was 507 million yuan. , a year-on-year decrease of 18.84%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 376 million yuan, a year-on-year decrease of 34.20%; basic earnings per share were 0.17 yuan; it is proposed to distribute a cash dividend of 0.30 yuan (tax included) for every 10 shares to all shareholders.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment